Summary: Wockhardt Ltd has signed an in-licensing agreement with Crawford Healthcare of UK to market Viticolor, a skin camouflage gel for vitiligo (leucoderma) patients. Earlier this week, Wockhardt signed a licensing deal with LSI of UK to market skincare drug Vitix in India. Viticolor will complement Vitix and further strengthen our Indian dermatology
Image Dimensions: 160 x 160
Image originally found here.